COVID-19 Bulletin 3/22/2020

A Texas physician’s argument for continuing to offer fertility treatments, based on the principles of justice, autonomy and “do no harm” perfectly articulates why CHR keeps its door open to patients during the COVID-19 crisis. Read the bulletin here.

Norbert Gleicher, MD, leads CHR’s clinical and research efforts as Medical Director and Chief Scientist. A world-renowned reproductive endocrinologist, Dr. Gleicher has published hundreds of peer-reviewed papers and lectured globally while keeping an active clinical career focused on ovarian aging, immunological issues and other difficult cases of infertility.